Corrigendum to "Aberrant upregulation of CDK1 contributes to medroxyprogesterone acetate (MPA) resistance in cancer-associated fibroblasts of the endometrium" [Biochem. Biophys. Res. Commun. 628 (2022) 133-140].

Intan Sofia Omar Noor Azmi Mat Adenan Alejandro Godoy Ik Hui Teo Yogeeta Gunasagran Ivy Chung

Biochem Biophys Res Commun

Department of Pharmacology, Faculty of Medicine, Universiti Malaya, 50603, Kuala Lumpur, Malaysia; Universiti Malaya Cancer Research Institute, Faculty of Medicine, Universiti Malaya, 50603, Kuala Lumpur, Malaysia. Electronic address:

Published: January 2023

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.bbrc.2022.12.065	DOI Listing

Publication Analysis

Top Keywords

corrigendum "aberrant

"aberrant upregulation

upregulation cdk1

cdk1 contributes

contributes medroxyprogesterone

medroxyprogesterone acetate

acetate mpa

mpa resistance

resistance cancer-associated

cancer-associated fibroblasts

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!